Surgical Tissue Flap for Glioblastoma
This study is looking at a new surgical technique for people with newly diagnosed glioblastoma (a type of brain cancer). It involves using a piece of your own tissue, called a pedicled temporoparietal fascial (TPF) or pericranial flap, to line the area where the tumor was removed. The goal is to see if this procedure is safe and can help you live longer without the cancer growing (progression-free survival). Researchers will be looking at how long you live without the cancer progressing at 6 months. You might be able to join if you are 18 or older, are having surgery for glioblastoma, and are generally in good health with a life expectancy of at least 6 months.
- Study design
- This is a single-center study involving 32 participants. It is an open-label study, meaning both you and your doctors will know you are receiving the intervention.
- What's involved
- You will undergo standard surgery for glioblastoma, followed by the surgical tissue flap procedure. You will have follow-up visits to check for side effects at 72 hours, 7 days, 30 days, 60 days, 120 days, and 180 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be followed for side effects and progression-free survival for at least 6 months after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- John Boockvar, MD · PRINCIPAL_INVESTIGATOR · Feinstein Institute for Medical Research/Lenox Hill Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Progression Free Survival (PFS)6 months
PFS is defined as time from surgery until first known disease progression or death from any cause, whichever occurs first.